| ADE (Incidence %) | Antineoplastons | Lashford et al., 2002, Temozolomide [21] | Warren et al., 2012, 06‑Benzylguanine and Temozolomide [23] | ||
| Gr. 3 | Gr. 4 | Gr. 3/Gr. 4 | Gr. 3 | Gr. 4 | |
| Hypokalemia | 2.3 | ||||
| Hypernatremia | 4.6 | 13.9 | |||
| Fatigue | 1 | ||||
| Somnolence | 2.3 | 2.3 | |||
| Thrombocytopenia | 7 | 17 | 2 | ||
| Neutropenia | 12 | 32 | |||
| Leukopenia | 5 | 15 | 10 | ||
| Lymphopenia | 24 | 2 | |||
| Anemia | 7 | ||||
| Vomiting | 2 | 2 | |||
| Anorexia | <1 | ||||
| Infection | 5 | ||||
| Sepsis | 2 | ||||
| Pneumonia | 2 | ||||
| Fever | |||||
| Neuropathy | <1 | ||||
| Seizures | <1 | ||||
| Headache | 2 | ||||
| Pain | <1 | ||||